Effects of Specific Genes Activating RAGE on Polycystic Kidney Disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Eun Young | - |
dc.contributor.author | Seo, Min Ji | - |
dc.contributor.author | Park, Jong Hoon | - |
dc.date.available | 2021-02-22T14:02:53Z | - |
dc.date.issued | 2010-08 | - |
dc.identifier.issn | 0250-8095 | - |
dc.identifier.issn | 1421-9670 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/13595 | - |
dc.description.abstract | Background: Autosomal-dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst formation and secretion of fluid and is associated with interstitial inflammation and fibrosis, resulting in the loss of renal function. We previously generated mice overexpressing PKD2, causing progressive cyst development with an inflammatory and fibrotic phenotype in the kidneys. Methods: To profile the gene expression related to inflammation and cystogenesis, microarray analysis was performed with kidney tissue from 6-, 12- and 18-month-old mice. Subsequently, levels and related mechanisms of selected genes, s100a8 and s100a9, were evaluated. Results: S100a8 and s100a9 was upregulated more than 2-fold and differently expressed in the cystic region. Receptor of advanced glycation end product (RAGE) is a putative cell surface receptor for s100a8/a9. It was expressed in cyst-lining cells and up-regulated pro-inflammatory transcription factor NF-kappa B in transgenic mice. We also confirmed RAGE expression in ADPKD patient kidneys. It was suggested that the signaling related to proliferative cystogenesis through previous reports; therefore, we confirmed that phosphorylated-ERK and cyst formation was reduced by treatment of RAGE-siRNA. Conclusions: The results may provide important information for the expression of s100a8/a9 and RAGE, linking progressive cystogenesis with inflammation in cystic kidney. Copyright (C) 2010 S. Karger AG, Basel | - |
dc.format.extent | 10 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | KARGER | - |
dc.title | Effects of Specific Genes Activating RAGE on Polycystic Kidney Disease | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.1159/000315859 | - |
dc.identifier.scopusid | 2-s2.0-77954197019 | - |
dc.identifier.wosid | 000280476600010 | - |
dc.identifier.bibliographicCitation | AMERICAN JOURNAL OF NEPHROLOGY, v.32, no.2, pp 169 - 178 | - |
dc.citation.title | AMERICAN JOURNAL OF NEPHROLOGY | - |
dc.citation.volume | 32 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 169 | - |
dc.citation.endPage | 178 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | CELL-PROLIFERATION | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | PROTEINS | - |
dc.subject.keywordPlus | FIBROSIS | - |
dc.subject.keywordPlus | ADPKD | - |
dc.subject.keywordPlus | PKD2 | - |
dc.subject.keywordAuthor | Autosomal-dominant polycystic kidney disease | - |
dc.subject.keywordAuthor | Receptor of advanced glycation end product | - |
dc.subject.keywordAuthor | Cell proliferation | - |
dc.subject.keywordAuthor | Cystogenesis | - |
dc.identifier.url | https://www.karger.com/Article/Abstract/315859 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.